{"adverse_reactions":["ADVERSE REACTIONS to report suspected adverse reactions 1-800-FDA-1088"],"effective_time":"20240209","id":"2a5216c8-0277-430c-a4de-d058f38a7b46","openfda":{},"package_label_principal_display_panel":["PRINCIPAL DISPLAY PANEL NDC 0143- 9396 -01 Rx only Cisatracurium Besylate Injection, USP 10 mg per 5 mL (2 mg/mL) WARNING: Paralyzing Agent For Intravenous Use 5 mL Single-Dose Vial NDC 0143- 9396 -01 Rx only Cisatracurium Besylate Injection, USP 10 mg per 5 mL (2 mg/mL) WARNING: Paralyzing Agent For Intravenous Use 5 mL Single-Dose Vial x 1 Cisatra unit label Cisatra carton"],"set_id":"0273051b-fbeb-451c-b240-c524101181f4","spl_product_data_elements":["Cisatracurium Besylate Cisatracurium Besylate CISATRACURIUM BESYLATE CISATRACURIUM WATER BENZENESULFINIC ACID"],"version":"7"}